Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Turkey

Actavis Launching New Generics

October 2006 | Product Launch

Icelandic drugmaker Actavis has launched three new generic drugs in Turkey, as the company continues to expand in the country. The three products include Xetanor (paroxetine), an antidepressant in SSRI class, as well as the hypertension treatment Blockace (ramipiril) and the antihistamine Vivafeks (Fexofenadine).

To read the full article, please choose one of the following options:

Subcribers please log in

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries